Biosimilar Drug Market - Global Outlook and Forecast 2022-2028

Biosimilar Drug Market - Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Biosimilar Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilar Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilar Drug Overall Market Size
2.1 Global Biosimilar Drug Market Size: 2021 VS 2028
2.2 Global Biosimilar Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Biosimilar Drug Sales: 2017-2028
3 Company Landscape
3.1 Top Biosimilar Drug Players in Global Market
3.2 Top Global Biosimilar Drug Companies Ranked by Revenue
3.3 Global Biosimilar Drug Revenue by Companies
3.4 Global Biosimilar Drug Sales by Companies
3.5 Global Biosimilar Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Biosimilar Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Biosimilar Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biosimilar Drug Players in Global Market
3.8.1 List of Global Tier 1 Biosimilar Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Biosimilar Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biosimilar Drug Market Size Markets, 2021 & 2028
4.1.2 Injection
4.1.3 Tablets
4.1.4 Other Types
4.2 By Type - Global Biosimilar Drug Revenue & Forecasts
4.2.1 By Type - Global Biosimilar Drug Revenue, 2017-2022
4.2.2 By Type - Global Biosimilar Drug Revenue, 2023-2028
4.2.3 By Type - Global Biosimilar Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Biosimilar Drug Sales & Forecasts
4.3.1 By Type - Global Biosimilar Drug Sales, 2017-2022
4.3.2 By Type - Global Biosimilar Drug Sales, 2023-2028
4.3.3 By Type - Global Biosimilar Drug Sales Market Share, 2017-2028
4.4 By Type - Global Biosimilar Drug Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Biosimilar Drug Market Size, 2021 & 2028
5.1.2 Ankylosing Spondylitis
5.1.3 Tumor
5.1.4 Rheumatoid Arthrtis
5.1.5 Cardiovascular
5.1.6 Other Application
5.2 By Application - Global Biosimilar Drug Revenue & Forecasts
5.2.1 By Application - Global Biosimilar Drug Revenue, 2017-2022
5.2.2 By Application - Global Biosimilar Drug Revenue, 2023-2028
5.2.3 By Application - Global Biosimilar Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Biosimilar Drug Sales & Forecasts
5.3.1 By Application - Global Biosimilar Drug Sales, 2017-2022
5.3.2 By Application - Global Biosimilar Drug Sales, 2023-2028
5.3.3 By Application - Global Biosimilar Drug Sales Market Share, 2017-2028
5.4 By Application - Global Biosimilar Drug Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Biosimilar Drug Market Size, 2021 & 2028
6.2 By Region - Global Biosimilar Drug Revenue & Forecasts
6.2.1 By Region - Global Biosimilar Drug Revenue, 2017-2022
6.2.2 By Region - Global Biosimilar Drug Revenue, 2023-2028
6.2.3 By Region - Global Biosimilar Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Biosimilar Drug Sales & Forecasts
6.3.1 By Region - Global Biosimilar Drug Sales, 2017-2022
6.3.2 By Region - Global Biosimilar Drug Sales, 2023-2028
6.3.3 By Region - Global Biosimilar Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Biosimilar Drug Revenue, 2017-2028
6.4.2 By Country - North America Biosimilar Drug Sales, 2017-2028
6.4.3 US Biosimilar Drug Market Size, 2017-2028
6.4.4 Canada Biosimilar Drug Market Size, 2017-2028
6.4.5 Mexico Biosimilar Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Biosimilar Drug Revenue, 2017-2028
6.5.2 By Country - Europe Biosimilar Drug Sales, 2017-2028
6.5.3 Germany Biosimilar Drug Market Size, 2017-2028
6.5.4 France Biosimilar Drug Market Size, 2017-2028
6.5.5 U.K. Biosimilar Drug Market Size, 2017-2028
6.5.6 Italy Biosimilar Drug Market Size, 2017-2028
6.5.7 Russia Biosimilar Drug Market Size, 2017-2028
6.5.8 Nordic Countries Biosimilar Drug Market Size, 2017-2028
6.5.9 Benelux Biosimilar Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Biosimilar Drug Revenue, 2017-2028
6.6.2 By Region - Asia Biosimilar Drug Sales, 2017-2028
6.6.3 China Biosimilar Drug Market Size, 2017-2028
6.6.4 Japan Biosimilar Drug Market Size, 2017-2028
6.6.5 South Korea Biosimilar Drug Market Size, 2017-2028
6.6.6 Southeast Asia Biosimilar Drug Market Size, 2017-2028
6.6.7 India Biosimilar Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Biosimilar Drug Revenue, 2017-2028
6.7.2 By Country - South America Biosimilar Drug Sales, 2017-2028
6.7.3 Brazil Biosimilar Drug Market Size, 2017-2028
6.7.4 Argentina Biosimilar Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biosimilar Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Biosimilar Drug Sales, 2017-2028
6.8.3 Turkey Biosimilar Drug Market Size, 2017-2028
6.8.4 Israel Biosimilar Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Biosimilar Drug Market Size, 2017-2028
6.8.6 UAE Biosimilar Drug Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 CP Guojian Pharma
7.1.1 CP Guojian Pharma Corporate Summary
7.1.2 CP Guojian Pharma Business Overview
7.1.3 CP Guojian Pharma Biosimilar Drug Major Product Offerings
7.1.4 CP Guojian Pharma Biosimilar Drug Sales and Revenue in Global (2017-2022)
7.1.5 CP Guojian Pharma Key News
7.2 Biotech Pharma
7.2.1 Biotech Pharma Corporate Summary
7.2.2 Biotech Pharma Business Overview
7.2.3 Biotech Pharma Biosimilar Drug Major Product Offerings
7.2.4 Biotech Pharma Biosimilar Drug Sales and Revenue in Global (2017-2022)
7.2.5 Biotech Pharma Key News
7.3 Celgen Pharma
7.3.1 Celgen Pharma Corporate Summary
7.3.2 Celgen Pharma Business Overview
7.3.3 Celgen Pharma Biosimilar Drug Major Product Offerings
7.3.4 Celgen Pharma Biosimilar Drug Sales and Revenue in Global (2017-2022)
7.3.5 Celgen Pharma Key News
7.4 Henlius
7.4.1 Henlius Corporate Summary
7.4.2 Henlius Business Overview
7.4.3 Henlius Biosimilar Drug Major Product Offerings
7.4.4 Henlius Biosimilar Drug Sales and Revenue in Global (2017-2022)
7.4.5 Henlius Key News
7.5 Amgen
7.5.1 Amgen Corporate Summary
7.5.2 Amgen Business Overview
7.5.3 Amgen Biosimilar Drug Major Product Offerings
7.5.4 Amgen Biosimilar Drug Sales and Revenue in Global (2017-2022)
7.5.5 Amgen Key News
7.6 Eli Lilly
7.6.1 Eli Lilly Corporate Summary
7.6.2 Eli Lilly Business Overview
7.6.3 Eli Lilly Biosimilar Drug Major Product Offerings
7.6.4 Eli Lilly Biosimilar Drug Sales and Revenue in Global (2017-2022)
7.6.5 Eli Lilly Key News
7.7 Sandoz
7.7.1 Sandoz Corporate Summary
7.7.2 Sandoz Business Overview
7.7.3 Sandoz Biosimilar Drug Major Product Offerings
7.7.4 Sandoz Biosimilar Drug Sales and Revenue in Global (2017-2022)
7.7.5 Sandoz Key News
7.8 Changchun High Tech
7.8.1 Changchun High Tech Corporate Summary
7.8.2 Changchun High Tech Business Overview
7.8.3 Changchun High Tech Biosimilar Drug Major Product Offerings
7.8.4 Changchun High Tech Biosimilar Drug Sales and Revenue in Global (2017-2022)
7.8.5 Changchun High Tech Key News
7.9 Innovent
7.9.1 Innovent Corporate Summary
7.9.2 Innovent Business Overview
7.9.3 Innovent Biosimilar Drug Major Product Offerings
7.9.4 Innovent Biosimilar Drug Sales and Revenue in Global (2017-2022)
7.9.5 Innovent Key News
8 Global Biosimilar Drug Production Capacity, Analysis
8.1 Global Biosimilar Drug Production Capacity, 2017-2028
8.2 Biosimilar Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Biosimilar Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biosimilar Drug Supply Chain Analysis
10.1 Biosimilar Drug Industry Value Chain
10.2 Biosimilar Drug Upstream Market
10.3 Biosimilar Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biosimilar Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Biosimilar Drug in Global Market
Table 2. Top Biosimilar Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Biosimilar Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Biosimilar Drug Revenue Share by Companies, 2017-2022
Table 5. Global Biosimilar Drug Sales by Companies, (K Dose), 2017-2022
Table 6. Global Biosimilar Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Biosimilar Drug Price (2017-2022) & (USD/Dose)
Table 8. Global Manufacturers Biosimilar Drug Product Type
Table 9. List of Global Tier 1 Biosimilar Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biosimilar Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Biosimilar Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Biosimilar Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Biosimilar Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Biosimilar Drug Sales (K Dose), 2017-2022
Table 15. By Type - Global Biosimilar Drug Sales (K Dose), 2023-2028
Table 16. By Application - Global Biosimilar Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Biosimilar Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Biosimilar Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Biosimilar Drug Sales (K Dose), 2017-2022
Table 20. By Application - Global Biosimilar Drug Sales (K Dose), 2023-2028
Table 21. By Region - Global Biosimilar Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Biosimilar Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Biosimilar Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Biosimilar Drug Sales (K Dose), 2017-2022
Table 25. By Region - Global Biosimilar Drug Sales (K Dose), 2023-2028
Table 26. By Country - North America Biosimilar Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Biosimilar Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Biosimilar Drug Sales, (K Dose), 2017-2022
Table 29. By Country - North America Biosimilar Drug Sales, (K Dose), 2023-2028
Table 30. By Country - Europe Biosimilar Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Biosimilar Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Biosimilar Drug Sales, (K Dose), 2017-2022
Table 33. By Country - Europe Biosimilar Drug Sales, (K Dose), 2023-2028
Table 34. By Region - Asia Biosimilar Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Biosimilar Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Biosimilar Drug Sales, (K Dose), 2017-2022
Table 37. By Region - Asia Biosimilar Drug Sales, (K Dose), 2023-2028
Table 38. By Country - South America Biosimilar Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Biosimilar Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Biosimilar Drug Sales, (K Dose), 2017-2022
Table 41. By Country - South America Biosimilar Drug Sales, (K Dose), 2023-2028
Table 42. By Country - Middle East & Africa Biosimilar Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Biosimilar Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Biosimilar Drug Sales, (K Dose), 2017-2022
Table 45. By Country - Middle East & Africa Biosimilar Drug Sales, (K Dose), 2023-2028
Table 46. CP Guojian Pharma Corporate Summary
Table 47. CP Guojian Pharma Biosimilar Drug Product Offerings
Table 48. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 49. Biotech Pharma Corporate Summary
Table 50. Biotech Pharma Biosimilar Drug Product Offerings
Table 51. Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 52. Celgen Pharma Corporate Summary
Table 53. Celgen Pharma Biosimilar Drug Product Offerings
Table 54. Celgen Pharma Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 55. Henlius Corporate Summary
Table 56. Henlius Biosimilar Drug Product Offerings
Table 57. Henlius Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 58. Amgen Corporate Summary
Table 59. Amgen Biosimilar Drug Product Offerings
Table 60. Amgen Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 61. Eli Lilly Corporate Summary
Table 62. Eli Lilly Biosimilar Drug Product Offerings
Table 63. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 64. Sandoz Corporate Summary
Table 65. Sandoz Biosimilar Drug Product Offerings
Table 66. Sandoz Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 67. Changchun High Tech Corporate Summary
Table 68. Changchun High Tech Biosimilar Drug Product Offerings
Table 69. Changchun High Tech Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 70. Innovent Corporate Summary
Table 71. Innovent Biosimilar Drug Product Offerings
Table 72. Innovent Biosimilar Drug Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 73. Biosimilar Drug Production Capacity (K Dose) of Key Manufacturers in Global Market, 2020-2022 (K Dose)
Table 74. Global Biosimilar Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Biosimilar Drug Production by Region, 2017-2022 (K Dose)
Table 76. Global Biosimilar Drug Production by Region, 2023-2028 (K Dose)
Table 77. Biosimilar Drug Market Opportunities & Trends in Global Market
Table 78. Biosimilar Drug Market Drivers in Global Market
Table 79. Biosimilar Drug Market Restraints in Global Market
Table 80. Biosimilar Drug Raw Materials
Table 81. Biosimilar Drug Raw Materials Suppliers in Global Market
Table 82. Typical Biosimilar Drug Downstream
Table 83. Biosimilar Drug Downstream Clients in Global Market
Table 84. Biosimilar Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biosimilar Drug Segment by Type
Figure 2. Biosimilar Drug Segment by Application
Figure 3. Global Biosimilar Drug Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Biosimilar Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biosimilar Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Biosimilar Drug Sales in Global Market: 2017-2028 (K Dose)
Figure 8. The Top 3 and 5 Players Market Share by Biosimilar Drug Revenue in 2021
Figure 9. By Type - Global Biosimilar Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Biosimilar Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Biosimilar Drug Price (USD/Dose), 2017-2028
Figure 12. By Application - Global Biosimilar Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Biosimilar Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Biosimilar Drug Price (USD/Dose), 2017-2028
Figure 15. By Region - Global Biosimilar Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Biosimilar Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Biosimilar Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Biosimilar Drug Sales Market Share, 2017-2028
Figure 19. US Biosimilar Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Biosimilar Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Biosimilar Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Biosimilar Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Biosimilar Drug Sales Market Share, 2017-2028
Figure 24. Germany Biosimilar Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Biosimilar Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Biosimilar Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Biosimilar Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Biosimilar Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Biosimilar Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Biosimilar Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Biosimilar Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Biosimilar Drug Sales Market Share, 2017-2028
Figure 33. China Biosimilar Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Biosimilar Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Biosimilar Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Biosimilar Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Biosimilar Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Biosimilar Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Biosimilar Drug Sales Market Share, 2017-2028
Figure 40. Brazil Biosimilar Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Biosimilar Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Biosimilar Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Biosimilar Drug Sales Market Share, 2017-2028
Figure 44. Turkey Biosimilar Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Biosimilar Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Biosimilar Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Biosimilar Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Biosimilar Drug Production Capacity (K Dose), 2017-2028
Figure 49. The Percentage of Production Biosimilar Drug by Region, 2020 VS 2027
Figure 50. Biosimilar Drug Industry Value Chain
Figure 51. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147

According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......

Global Biosimilar Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......

Global Biosimilars Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......

Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs